Literature DB >> 12700642

Hijacking Rho GTPases by protein toxins and apoptosis: molecular strategies of pathogenic bacteria.

C Fiorentini1, L Falzano, S Travaglione, A Fabbri.   

Abstract

Certain bacterial toxins and type-III-translocated virulence factors have a peculiar property: they exert part of their actions by modulating Rho GTPases. These toxins target the actin cytoskeleton of host cells and reorganize it to their own advantage, either to facilitate macropinocytosis, which is required for invasive bacteria to enter cells, or to block pathogen sequestration by macrophages. In addition, by acting on Rho GTPases, bacteria may also interfere with the fate of host cells, favoring survival or death depending on their needs. Rho GTPases control the activation of NF-kappaB, which is involved in the expression of antiapoptotic proteins and mediates immunological responses as well. Here, we give a perspective on how NF-kappaB may participate in linking Rho-acting toxins and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700642     DOI: 10.1038/sj.cdd.4401151

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  24 in total

1.  Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes.

Authors:  Laurent Boyer; Sara Travaglione; Loredana Falzano; Nils C Gauthier; Michel R Popoff; Emmanuel Lemichez; Carla Fiorentini; Alessia Fabbri
Journal:  Mol Biol Cell       Date:  2003-12-10       Impact factor: 4.138

2.  Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity.

Authors:  Ann E Lin; Chloe A Autran; Sophia D Espanola; Lars Bode; Victor Nizet
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

3.  Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2.

Authors:  Alessandro Giamboi Miraglia; Sara Travaglione; Stefania Meschini; Loredana Falzano; Paola Matarrese; Maria Giovanna Quaranta; Marina Viora; Carla Fiorentini; Alessia Fabbri
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

4.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

Review 5.  Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host.

Authors:  Michel R Popoff
Journal:  Small GTPases       Date:  2014-05-08

6.  Hcp family proteins secreted via the type VI secretion system coordinately regulate Escherichia coli K1 interaction with human brain microvascular endothelial cells.

Authors:  Yan Zhou; Jing Tao; Hao Yu; Jinjing Ni; Lingbing Zeng; Qihui Teng; Kwang Sik Kim; Guo-Ping Zhao; Xiaokui Guo; Yufeng Yao
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

7.  Modulation of host microtubule dynamics by pathogenic bacteria.

Authors:  Girish K Radhakrishnan; Gary A Splitter
Journal:  Biomol Concepts       Date:  2012-12-01

8.  Vibrio parahaemolyticus inhibition of Rho family GTPase activation requires a functional chromosome I type III secretion system.

Authors:  Timothy Casselli; Tarah Lynch; Carolyn M Southward; Bryan W Jones; Rebekah DeVinney
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Differential regulation of macropinocytosis by Abi1/Hssh3bp1 isoforms.

Authors:  Patrycja M Dubielecka; Ping Cui; Xiaoling Xiong; Sajjad Hossain; Susanne Heck; Lyudmil Angelov; Leszek Kotula
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

10.  Genome comparison of the epiphytic bacteria Erwinia billingiae and E. tasmaniensis with the pear pathogen E. pyrifoliae.

Authors:  Michael Kube; Alexander M Migdoll; Isabel Gehring; Katja Heitmann; Yvonne Mayer; Heiner Kuhl; Florian Knaust; Klaus Geider; Richard Reinhardt
Journal:  BMC Genomics       Date:  2010-06-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.